To validate novel SNVs using base editing, we chose four highly ranked candidate genes, DAPK3, UBE2B, USP44, and PTPN11, each with a specific CHD-associated missense mutation (Homsy et al., 2015; Zaidi et al., 2013). This evidence concerns the gene UBE2B and coronary artery disorder.